Physician Education: Bridging Clinical Research and Patient Care

Antiretroviral Therapy: Caring for HIV-Infected Patients and Preventing HIV Transmission

Tuesday, October 25, 2016

2:00 PM (ET), 1:00 PM (CT), 12:00 PM (MT), 11:00 AM (PT)


Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. Over the past decade, the rate of new HIV diagnoses in the United States has declined by 19%, with an estimated 44,073 new HIV infections diagnosed in 2014. In recent years, new data have emerged about the efficacy of antiretroviral therapy to decrease the likelihood of HIV transmission for effectively treated HIV-infected persons and to decrease the risk of acquiring HIV infection for HIV-uninfected at-risk individuals. This activity will discuss the effects of antiretroviral medications on HIV transmission and acquisition, and will discuss best practices that clinicians can use when caring for patients, to decrease the spread of HIV.

Learning Objectives

At the conclusion of this webinar, participants will be able to:

  • Assess the appropriate indications for initiation of antiretroviral therapy with regard to its preventive benefit
  • List the reasons why HIV-infected patients may not fully engage in care or optimally benefit from treatment
  • Determine the additional benefit that preexposure prophylaxis (PrEP) may provide to partners of HIV-infected individuals


Who Should Attend

This webinar is designed for physicians who are involved in HIV care and prevention.

This activity is also relevant for other clinicians, including nurse practitioners and other nursing professionals, physician assistants, and pharmacists.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Monday, October 24, 2016, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration“at” or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-16-270-L02-P

Grant Support

This activity is funded by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS).

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration“at” or 415-544-9400.


Webinar Link

You may view or share the archived recording for educational purposes, however, it is not available for CME credit.